SUSANBLANEYSUSAN BLANEY0.000000000000000.000000000000003463BLANEY, SUSANSusan M. Blaney, M.D. is the David G. Poplack, MD Chair in Pediatric Oncology and The Elise C. Young Chair in Pediatrics Oncology. She is Professor in the Department of Pediatrics at Baylor College of Medicine (BCM) where she serves as the Division Chief in Pediatric Hematology-Oncology. She is also the Director of Texas Children's Cancer and Hematology Center at Texas Children's Hospital. She has extensive experience in clinical and translational research with a focus on the development of new treatment strategies for children with brain tumors and other refractory cancers. In the past, she served as the Vice President for Clinical and Translational Research at BCM, Executive Vice Chair of the Department of Pediatrics, Vice Chair for the Children’s Oncology Group, an international clinical trial cooperative group supported by the National Cancer Institute (NCI), and Chair of the NCI's Pediatric Phase 1 and Pilot Consortium. She has served on the Clinical Trial Advisory Committee for the National Cancer Institute and as a consultant of the FDA’s pediatric Oncology Drug Advisory Committee.Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:overviewoverviewvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson24908656Su JM, Thompson P, Adesina A, Li XN, Kilburn L, Onar-Thomas A, Kocak M, Chyla B, McKeegan E, Warren KE, Goldman S, Pollack IF, Fouladi M, Chen A, Giranda V, Boyett J, Kun L, Blaney SMNeuro-oncologyA phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report. Neuro Oncol. 2014 Dec; 16(12):1661-8.Neuro Oncol2014-06-07T00:00:002014A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report.25257751Voss SD, Glade-Bender J, Spunt SL, DuBois SG, Widemann BC, Park JR, Leary SE, Nelson MD, Adamson PC, Blaney SM, Weigel BPediatric blood & cancerGrowth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium. Pediatr Blood Cancer. 2015 Jan; 62(1):45-51.Pediatr Blood Cancer2014-09-24T00:00:002014Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium.Authorship 800859Authorship 826065Authorship 858191Authorship 860318Authorship 8655110Authorship 873829Authorship 8949812Authorship 8971Authorship 909131Authorship 93338Authorship 932701Authorship 972487Authorship 9787411Authorship 98652Authorship 991811Authorship 1058379Authorship 1107843Authorship 113936Authorship 1141641Authorship 1151147Authorship 1155266Authorship 116636Authorship 12197Authorship 133384Authorship 136477Authorship 143101Authorship 149363Authorship 152721Authorship 1563513Authorship 172804Authorship 1959414Authorship 223448Authorship 240624Authorship 24512Authorship 249961Authorship 1605749Authorship 16060114Authorship 16183011Authorship 1623081325431212Kilburn LB, Kocak M, Decker RL, Wetmore C, Chintagumpala M, Su J, Goldman S, Banerjee A, Gilbertson R, Fouladi M, Kun L, Boyett JM, Blaney SMNeuro-oncologyA phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study. Neuro Oncol. 2015 Feb; 17(2):303-11.Neuro Oncol2014-11-27T00:00:002014A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study.25446280Wagner LM, Fouladi M, Ahmed A, Krailo MD, Weigel B, DuBois SG, Doyle LA, Chen H, Blaney SMPediatric blood & cancerPhase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2015 Mar; 62(3):440-4.Pediatr Blood Cancer2014-11-28T00:00:002014Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group.25467181Fouladi M, Perentesis JP, Wagner LM, Vinks AA, Reid JM, Ahern C, Thomas G, Mercer CA, Krueger DA, Houghton PJ, Doyle LA, Chen H, Weigel B, Blaney SMClinical cancer research : an official journal of the American Association for Cancer ResearchA Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report. Clin Cancer Res. 2015 Apr 01; 21(7):1558-65.Clin Cancer Res2014-12-02T00:00:002014A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report.25728527Kolb EA, Sampson V, Stabley D, Walter A, Sol-Church K, Cripe T, Hingorani P, Ahern CH, Weigel BJ, Zwiebel J, Blaney SMPediatric blood & cancerA phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium report. Pediatr Blood Cancer. 2015 May; 62(5):751-8.Pediatr Blood Cancer2015-02-27T00:00:002015A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium report.Authorship 2886110Authorship 298561Authorship 302748Authorship 349291Authorship 37364LeukemiaPalliative Care & Rehabilitation MedicineMD AndersonJORGE ECORTESJORGE E CORTES8637CORTES, JORGE EProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorEDUARDOBRUERAEDUARDO BRUERA8804BRUERA, EDUARDOProfessorELIAS JOSEPHJABBOURELIAS JOSEPH JABBOUR9124JABBOUR, ELIAS JOSEPHAssociate ProfessorGUILLERMOGARCIA-MANEROGUILLERMO GARCIA-MANERO8853GARCIA-MANERO, GUILLERMOProfessorAuthorship 44796Authorship 465882Authorship 48692Authorship 521071Authorship 530339Authorship 534052Authorship 551409Authorship 5861712Authorship 5907811Authorship 59792Authorship 627276Authorship 629967Authorship 653144Authorship 753326Authorship 78689Authorship 7965214Authorship 800782Authorship 819952Authorship 840883Authorship 845193Authorship 887943Authorship 896271Authorship 912468Authorship 93890625976292Loh ML, Tasian SK, Rabin KR, Brown P, Magoon D, Reid JM, Chen X, Ahern CH, Weigel BJ, Blaney SMPediatric blood & cancerA phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011). Pediatr Blood Cancer. 2015 Oct; 62(10):1717-24.Pediatr Blood Cancer2015-05-13T00:00:002015A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011).Pediatrics-Hem/Onc International8062195Izraeli S, Adamson PC, Blaney SM, Balis FMCancerAcute pancreatitis after ifosfamide therapy. Cancer. 1994 Sep 01; 74(5):1627-8.Cancer1994-09-01T00:00:001994Acute pancreatitis after ifosfamide therapy.8096760Blaney SM, Smith MA, Grem JLCancer treatment and researchDoxorubicin: role in the treatment of osteosarcoma. Cancer Treat Res. 1993; 62:55-73.Cancer Treat Res1993-01-01T00:00:001993Doxorubicin: role in the treatment of osteosarcoma.7923128Sung C, Blaney SM, Cole DE, Balis FM, Dedrick RLCancer researchA pharmacokinetic model of topotecan clearance from plasma and cerebrospinal fluid. Cancer Res. 1994 Oct 01; 54(19):5118-22.Cancer Res1994-10-01T00:00:001994A pharmacokinetic model of topotecan clearance from plasma and cerebrospinal fluid.8428353Blaney SM, Cole DE, Balis FM, Godwin K, Poplack DGCancer researchPlasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates. Cancer Res. 1993 Feb 15; 53(4):725-7.Cancer Res1993-02-15T00:00:001993Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates.8593019Blaney SM, Daniel MJ, Harker AJ, Godwin K, Balis FMAntimicrobial agents and chemotherapyPharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates. Antimicrob Agents Chemother. 1995 Dec; 39(12):2779-82.Antimicrob Agents Chemother1995-12-01T00:00:001995Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates.8697400Blaney SM, Phillips PC, Packer RJ, Heideman RL, Berg SL, Adamson PC, Allen JC, Sallan SE, Jakacki RI, Lange BJ, Reaman GH, Horowitz ME, Poplack DG, Balis FMCancerPhase II evaluation of topotecan for pediatric central nervous system tumors. Cancer. 1996 Aug 01; 78(3):527-31.Cancer1996-08-01T00:00:001996Phase II evaluation of topotecan for pediatric central nervous system tumors.7664282Adamson PC, Balis FM, Belasco JE, Lange B, Berg SL, Blaney SM, Craig C, Poplack DGCancer researchA phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer. Cancer Res. 1995 Sep 15; 55(18):4069-72.Cancer Res1995-09-15T00:00:001995A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer.7767947Blaney SM, Cole DE, Godwin K, Sung C, Poplack DG, Balis FMCancer chemotherapy and pharmacologyIntrathecal administration of topotecan in nonhuman primates. Cancer Chemother Pharmacol. 1995; 36(2):121-4.Cancer Chemother Pharmacol1995-01-01T00:00:001995Intrathecal administration of topotecan in nonhuman primates.7799017Blaney SM, Poplack DG, Godwin K, McCully CL, Murphy R, Balis FMJournal of clinical oncology : official journal of the American Society of Clinical OncologyEffect of body position on ventricular CSF methotrexate concentration following intralumbar administration. J Clin Oncol. 1995 Jan; 13(1):177-9.J Clin Oncol1995-01-01T00:00:001995Effect of body position on ventricular CSF methotrexate concentration following intralumbar administration.9193350Blaney SM, Seibel NL, O'Brien M, Reaman GH, Berg SL, Adamson PC, Poplack DG, Krailo MD, Mosher R, Balis FMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial. J Clin Oncol. 1997 Apr; 15(4):1538-43.J Clin Oncol1997-04-01T00:00:001997Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial.9363862Adamson PC, Reaman G, Finklestein JZ, Feusner J, Berg SL, Blaney SM, O'Brien M, Murphy RF, Balis FMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer. J Clin Oncol. 1997 Nov; 15(11):3330-7.J Clin Oncol1997-11-01T00:00:001997Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer.9696375Blaney SM, Poplack DGJournal of neuro-oncologyNew cytotoxic drugs for intrathecal administration. J Neurooncol. 1998 Jun-Jul; 38(2-3):219-23.J Neurooncol1998-06-01T00:00:001998New cytotoxic drugs for intrathecal administration.8439950Blaney SM, Balis FM, Cole DE, Craig C, Reid JM, Ames MM, Krailo M, Reaman G, Hammond D, Poplack DGCancer researchPediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion. Cancer Res. 1993 Mar 01; 53(5):1032-6.Cancer Res1993-03-01T00:00:001993Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion.10525111Kitchen BJ, Moser A, Lowe E, Balis FM, Widemann B, Anderson L, Strong J, Blaney SM, Berg SL, O'Brien M, Adamson PCThe Journal of pharmacology and experimental therapeuticsThioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxy-thioguanine. J Pharmacol Exp Ther. 1999 Nov; 291(2):870-4.J Pharmacol Exp Ther1999-11-01T00:00:001999Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxy-thioguanine.8471071Blaney SM, Grem JL, Balis FM, Cole DE, Adamson PC, Poplack DGBiochemical pharmacologyMechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts. Biochem Pharmacol. 1993 Apr 06; 45(7):1493-501.Biochem Pharmacol1993-04-06T00:00:001993Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts.10598660Bernstein ML, Baruchel S, Devine S, Markoglou N, Wainer IW, Williams M, Blaney S, Moghrabi A, Winick N, Vietti TJournal of pediatric hematology/oncologyPhase I and pharmacokinetic study of CI-980 in recurrent pediatric solid tumor cases: a Pediatric Oncology Group study. J Pediatr Hematol Oncol. 1999 Nov-Dec; 21(6):494-500.J Pediatr Hematol Oncol1999-11-01T00:00:001999Phase I and pharmacokinetic study of CI-980 in recurrent pediatric solid tumor cases: a Pediatric Oncology Group study.Authorship 2963527Authorship 30288212Authorship 3035231025930724Hoffman LM, Fouladi M, Olson J, Daryani VM, Stewart CF, Wetmore C, Kocak M, Onar-Thomas A, Wagner L, Gururangan S, Packer RJ, Blaney SM, Gajjar A, Kun LE, Boyett JM, Gilbertson RJChild's nervous system : ChNS : official journal of the International Society for Pediatric NeurosurgeryPhase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study. Childs Nerv Syst. 2015 Aug; 31(8):1283-9.Childs Nerv Syst2015-05-01T00:00:002015Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.26207356Kim A, Widemann BC, Krailo M, Jayaprakash N, Fox E, Weigel B, Blaney SMPediatric blood & cancerPhase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2015 Sep; 62(9):1562-6.Pediatr Blood Cancer2015-04-27T00:00:002015Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group.10213206Seibel NL, Blaney SM, O'Brien M, Krailo M, Hutchinson R, Mosher RB, Balis FM, Reaman GHClinical cancer research : an official journal of the American Association for Cancer ResearchPhase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial. Clin Cancer Res. 1999 Apr; 5(4):733-7.Clin Cancer Res1999-04-01T00:00:001999Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial.11793091Goldstein SL, Murry DJ, May S, Aleksic A, Sowinski KM, Blaney SPediatric nephrology (Berlin, Germany)Meropenem pharmacokinetics in children and adolescents receiving hemodialysis. Pediatr Nephrol. 2001 Dec; 16(12):1015-8.Pediatr Nephrol2001-12-01T00:00:002001Meropenem pharmacokinetics in children and adolescents receiving hemodialysis.1596909Blaney SM, Balis FM, Grem J, Cole DE, Adamson PC, Poplack DGCancer researchModulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine. Cancer Res. 1992 Jun 15; 52(12):3503-5.Cancer Res1992-06-15T00:00:001992Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine.12114450Egorin MJ, Zuhowski EG, McCully CM, Blaney SM, Kerr JZ, Berg SL, Balis FMClinical cancer research : an official journal of the American Association for Cancer ResearchPharmacokinetics of intrathecal gemcitabine in nonhuman primates. Clin Cancer Res. 2002 Jul; 8(7):2437-42.Clin Cancer Res2002-07-01T00:00:002002Pharmacokinetics of intrathecal gemcitabine in nonhuman primates.9516923Blaney SM, Needle MN, Gillespie A, Sato JK, Reaman GH, Berg SL, Adamson PC, Krailo MD, Bleyer WA, Poplack DG, Balis FMClinical cancer research : an official journal of the American Association for Cancer ResearchPhase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Clin Cancer Res. 1998 Feb; 4(2):357-60.Clin Cancer Res1998-02-01T00:00:001998Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.9544171Parikh SH, Chintagumpala M, Hicks MJ, Trautwein LM, Blaney S, Minifee P, Woo SYJournal of pediatric hematology/oncologyClear cell sarcoma of the kidney: an unusual presentation and review of the literature. J Pediatr Hematol Oncol. 1998 Mar-Apr; 20(2):165-8.J Pediatr Hematol Oncol1998-03-01T00:00:001998Clear cell sarcoma of the kidney: an unusual presentation and review of the literature.1661004Balis FM, Blaney SM, Poplack DGThe Pediatric infectious disease journalAntiretroviral drug development and clinical pharmacology. Pediatr Infect Dis J. 1991 Nov; 10(11):849-57.Pediatr Infect Dis J1991-11-01T00:00:001991Antiretroviral drug development and clinical pharmacology.11307057Chintagumpala M, Berg S, Blaney SMCurrent opinion in oncologyTreatment controversies in medulloblastoma. Curr Opin Oncol. 2001 May; 13(3):154-9.Curr Opin Oncol2001-05-01T00:00:002001Treatment controversies in medulloblastoma.14551735Renbarger J, Aleksic A, McGuffey L, Dauser R, Berg S, Blaney SCancer chemotherapy and pharmacologyPlasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates. Cancer Chemother Pharmacol. 2004 Jan; 53(1):39-42.Cancer Chemother Pharmacol2003-10-09T00:00:002003Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates.15150671Berg SL, Aleksic A, McGuffey L, Dauser R, Nuchtern J, Bernacky B, Blaney SMCancer chemotherapy and pharmacologyPlasma and cerebrospinal fluid pharmacokinetics of rebeccamycin (NSC 655649) in nonhuman primates. Cancer Chemother Pharmacol. 2004 Aug; 54(2):127-30.Cancer Chemother Pharmacol2004-05-18T00:00:002004Plasma and cerebrospinal fluid pharmacokinetics of rebeccamycin (NSC 655649) in nonhuman primates.15459213Bomgaars L, Geyer JR, Franklin J, Dahl G, Park J, Winick NJ, Klenke R, Berg SL, Blaney SMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis. J Clin Oncol. 2004 Oct 01; 22(19):3916-21.J Clin Oncol2004-10-01T00:00:002004Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.15514381Chintagumpala M, Blaney SM, Bomgaars LR, Aleksic A, Kuttesch JF, Klenke RA, Berg SLJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I and pharmacokinetic study of thalidomide with carboplatin in children with cancer. J Clin Oncol. 2004 Nov 01; 22(21):4394-400.J Clin Oncol2004-11-01T00:00:002004Phase I and pharmacokinetic study of thalidomide with carboplatin in children with cancer.15570082Blaney SM, Bernstein M, Neville K, Ginsberg J, Kitchen B, Horton T, Berg SL, Krailo M, Adamson PCJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015). J Clin Oncol. 2004 Dec 01; 22(23):4804-9.J Clin Oncol2004-12-01T00:00:002004Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015).74Professor10Assistant Professor13Associate Dean14Associate Professor47Distinguished Service Professor11054987Murry DJ, Blaney SMThe Annals of pharmacotherapyClinical pharmacology of encapsulated sustained-release cytarabine. Ann Pharmacother. 2000 Oct; 34(10):1173-8.Ann Pharmacother2000-10-01T00:00:002000Clinical pharmacology of encapsulated sustained-release cytarabine.15665281Wong KK, Chang YM, Tsang YT, Perlaky L, Su J, Adesina A, Armstrong DL, Bhattacharjee M, Dauser R, Blaney SM, Chintagumpala M, Lau CCCancer researchExpression analysis of juvenile pilocytic astrocytomas by oligonucleotide microarray reveals two potential subgroups. Cancer Res. 2005 Jan 01; 65(1):76-84.Cancer Res2005-01-01T00:00:002005Expression analysis of juvenile pilocytic astrocytomas by oligonucleotide microarray reveals two potential subgroups.11132217Berg SL, Blaney SM, Sullivan J, Bernstein M, Dubowy R, Harris MB, Pediatric Oncology GroupJournal of pediatric hematology/oncologyPhase II trial of pyrazoloacridine in children with solid tumors: a Pediatric Oncology Group phase II study. J Pediatr Hematol Oncol. 2000 Nov-Dec; 22(6):506-9.J Pediatr Hematol Oncol2000-11-01T00:00:002000Phase II trial of pyrazoloacridine in children with solid tumors: a Pediatric Oncology Group phase II study.15756014Horton TM, Blaney SM, Langevin AM, Kuhn J, Kamen B, Berg SL, Bernstein M, Weitman SClinical cancer research : an official journal of the American Association for Cancer ResearchPhase I trial and pharmacokinetic study of raltitrexed in children with recurrent or refractory leukemia: a pediatric oncology group study. Clin Cancer Res. 2005 Mar 01; 11(5):1884-9.Clin Cancer Res2005-03-01T00:00:002005Phase I trial and pharmacokinetic study of raltitrexed in children with recurrent or refractory leukemia: a pediatric oncology group study.11248578Kerr JZ, Berg S, Blaney SMCritical reviews in oncology/hematologyIntrathecal chemotherapy. Crit Rev Oncol Hematol. 2001 Mar; 37(3):227-36.Crit Rev Oncol Hematol2001-03-01T00:00:002001Intrathecal chemotherapy.12473573Houghton PJ, Adamson PC, Blaney S, Fine HA, Gorlick R, Haber M, Helman L, Hirschfeld S, Hollingshead MG, Israel MA, Lock RB, Maris JM, Merlino G, Patterson W, Reynolds CP, Shannon K, Yu A, Yu J, Smith MAClinical cancer research : an official journal of the American Association for Cancer ResearchTesting of new agents in childhood cancer preclinical models: meeting summary. Clin Cancer Res. 2002 Dec; 8(12):3646-57.Clin Cancer Res2002-12-01T00:00:002002Testing of new agents in childhood cancer preclinical models: meeting summary.12576438Souid AK, Dubowy RL, Blaney SM, Hershon L, Sullivan J, McLeod WD, Bernstein MLClinical cancer research : an official journal of the American Association for Cancer ResearchPhase I clinical and pharmacologic study of weekly cisplatin and irinotecan combined with amifostine for refractory solid tumors. Clin Cancer Res. 2003 Feb; 9(2):703-10.Clin Cancer Res2003-02-01T00:00:002003Phase I clinical and pharmacologic study of weekly cisplatin and irinotecan combined with amifostine for refractory solid tumors.11743213Bomgaars L, Berg SL, Blaney SMThe oncologistThe development of camptothecin analogs in childhood cancers. Oncologist. 2001; 6(6):506-16.Oncologist2001-01-01T00:00:002001The development of camptothecin analogs in childhood cancers.1102 BATESHouston, 77030TX16421428Widemann BC, Salzer WL, Arceci RJ, Blaney SM, Fox E, End D, Gillespie A, Whitcomb P, Palumbo JS, Pitney A, Jayaprakash N, Zannikos P, Balis FMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas. J Clin Oncol. 2006 Jan 20; 24(3):507-16.J Clin Oncol2006-01-20T00:00:002006Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas.16425266Jimeno A, Daw NC, Amador ML, Cusatis G, Kulesza P, Krailo M, Ingle AM, Blaney SM, Adamson P, Hidalgo M, Children's Oncology GroupPediatric blood & cancerAnalysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors. Pediatr Blood Cancer. 2007 Sep; 49(3):352-7.Pediatr Blood Cancer2007-09-01T00:00:002007Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors.16435380Hawkins DS, Bradfield S, Whitlock JA, Krailo M, Franklin J, Blaney SM, Adamson PC, Reaman GPediatric blood & cancerTopotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2006 Nov; 47(6):790-4.Pediatr Blood Cancer2006-11-01T00:00:002006Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study.16533779Gururangan S, Petros WP, Poussaint TY, Hancock ML, Phillips PC, Friedman HS, Bomgaars L, Blaney SM, Kun LE, Boyett JMClinical cancer research : an official journal of the American Association for Cancer ResearchPhase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004). Clin Cancer Res. 2006 Mar 01; 12(5):1540-6.Clin Cancer Res2006-03-01T00:00:002006Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).Authorship 321796127077669Blaney SM, Adamson PC, Wechsler DSPediatric blood & cancerThe 2016 ASPHO Distinguished Career Award Goes to David G. Poplack, MD. Pediatr Blood Cancer. 2016 Jun; 63 Suppl 1:S5-6.Pediatr Blood Cancer2016-06-01T00:00:002016The 2016 ASPHO Distinguished Career Award Goes to David G. Poplack, MD.16899619Shu Q, Antalffy B, Su JM, Adesina A, Ou CN, Pietsch T, Blaney SM, Lau CC, Li XNClinical cancer research : an official journal of the American Association for Cancer ResearchValproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts. Clin Cancer Res. 2006 Aug 01; 12(15):4687-94.Clin Cancer Res2006-08-01T00:00:002006Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts.Authorship 32533913Authorship 325730927400942Lagmay JP, Krailo MD, Dang H, Kim A, Hawkins DS, Beaty O, Widemann BC, Zwerdling T, Bomgaars L, Langevin AM, Grier HE, Weigel B, Blaney SM, Gorlick R, Janeway KAJournal of clinical oncology : official journal of the American Society of Clinical OncologyOutcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward. J Clin Oncol. 2016 09 01; 34(25):3031-8.J Clin Oncol2016-07-11T00:00:002016Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.27109549Wetmore C, Daryani VM, Billups CA, Boyett JM, Leary S, Tanos R, Goldsmith KC, Stewart CF, Blaney SM, Gajjar ACancer medicinePhase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021. Cancer Med. 2016 07; 5(7):1416-24.Cancer Med2016-04-25T00:00:002016Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021.17019740Fouladi M, Blaney SM, Poussaint TY, Freeman BB, McLendon R, Fuller C, Adesina AM, Hancock ML, Danks MK, Stewart C, Boyett JM, Gajjar ACancerPhase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study. Cancer. 2006 Nov 01; 107(9):2291-7.Cancer2006-11-01T00:00:002006Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.12506183Blaney SM, Heideman R, Berg S, Adamson P, Gillespie A, Geyer JR, Packer R, Matthay K, Jaeckle K, Cole D, Kuttesch N, Poplack DG, Balis FMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol. 2003 Jan 01; 21(1):143-7.J Clin Oncol2003-01-01T00:00:002003Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis.17262795Bond M, Bernstein ML, Pappo A, Schultz KR, Krailo M, Blaney SM, Adamson PCPediatric blood & cancerA phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2008 Feb; 50(2):254-8.Pediatr Blood Cancer2008-02-01T00:00:002008A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study.14871995Li XN, Parikh S, Shu Q, Jung HL, Chow CW, Perlaky L, Leung HC, Su J, Blaney S, Lau CCClinical cancer research : an official journal of the American Association for Cancer ResearchPhenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells. Clin Cancer Res. 2004 Feb 01; 10(3):1150-9.Clin Cancer Res2004-02-01T00:00:002004Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells.1727902Balis FM, Pizzo PA, Butler KM, Hawkins ME, Brouwers P, Husson RN, Jacobsen F, Blaney SM, Gress J, Jarosinski PThe Journal of infectious diseasesClinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children. J Infect Dis. 1992 Jan; 165(1):99-104.J Infect Dis1992-01-01T00:00:001992Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.15042312Berg SL, Stone J, Xiao JJ, Chan KK, Nuchtern J, Dauser R, McGuffey L, Thompson P, Blaney SMCancer chemotherapy and pharmacologyPlasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates. Cancer Chemother Pharmacol. 2004 Jul; 54(1):85-8.Cancer Chemother Pharmacol2004-03-23T00:00:002004Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates.17541590Stapleton SL, Thompson PA, Ou CN, Berg SL, McGuffey L, Gibson B, Blaney SMCancer chemotherapy and pharmacologyPlasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates. Cancer Chemother Pharmacol. 2008 Apr; 61(4):647-52.Cancer Chemother Pharmacol2007-05-31T00:00:002007Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates.15084615Aquino VM, Weitman SD, Winick NJ, Blaney S, Furman WL, Kepner JL, Bonate P, Krailo M, Qu W, Bernstein MJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study. J Clin Oncol. 2004 Apr 15; 22(8):1413-9.J Clin Oncol2004-04-15T00:00:002004Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study.17610262Langevin AM, Bernstein M, Kuhn JG, Blaney SM, Ivy P, Sun J, Chen Z, Adamson PC, Children's Oncology GroupPediatric blood & cancerA phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2008 Mar; 50(3):577-80.Pediatr Blood Cancer2008-03-01T00:00:002008A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study.17925558Bomgaars LR, Bernstein M, Krailo M, Kadota R, Das S, Chen Z, Adamson PC, Blaney SMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2007 Oct 10; 25(29):4622-7.J Clin Oncol2007-10-10T00:00:002007Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study.17941066Adams DM, Zhou T, Berg SL, Bernstein M, Neville K, Blaney SM, Children's Oncology GroupPediatric blood & cancerPhase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2008 Mar; 50(3):549-53.Pediatr Blood Cancer2008-03-01T00:00:002008Phase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors: a Children's Oncology Group study.12847318Langevin AM, Weitman SD, Kuhn JG, Weintraub ST, Baruchel S, Furman W, Bernstein M, Blaney S, Vietti T, Pediatric Oncology Group StudyJournal of pediatric hematology/oncologyPhase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study. J Pediatr Hematol Oncol. 2003 Jul; 25(7):526-33.J Pediatr Hematol Oncol2003-07-01T00:00:002003Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study.12847320Hayashi RJ, Blaney S, Sullivan J, Weitman S, Vietti T, Bernstein ML, Pediatric Oncology Group StudyJournal of pediatric hematology/oncologyPhase 1 study of Paclitaxel administered twice weekly to children with refractory solid tumors: a pediatric oncology group study. J Pediatr Hematol Oncol. 2003 Jul; 25(7):539-42.J Pediatr Hematol Oncol2003-07-01T00:00:002003Phase 1 study of Paclitaxel administered twice weekly to children with refractory solid tumors: a pediatric oncology group study.12879279Thompson P, Balis F, Serabe BM, Berg S, Adamson P, Klenke R, Aiken A, Packer R, Murry DJ, Jakacki R, Blaney SMCancer chemotherapy and pharmacologyPharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancer. Cancer Chemother Pharmacol. 2003 Nov; 52(5):417-23.Cancer Chemother Pharmacol2003-07-15T00:00:002003Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancer.18281546Gururangan S, Turner CD, Stewart CF, O'Shaughnessy M, Kocak M, Poussaint TY, Phillips PC, Goldman S, Packer R, Pollack IF, Blaney SM, Karsten V, Gerson SL, Boyett JM, Friedman HS, Kun LEClinical cancer research : an official journal of the American Association for Cancer ResearchPhase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study. Clin Cancer Res. 2008 Feb 15; 14(4):1124-30.Clin Cancer Res2008-02-15T00:00:002008Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study.15297409Neville K, Blaney S, Bernstein M, Thompson P, Adams D, Aleksic A, Berg SClinical cancer research : an official journal of the American Association for Cancer ResearchPharmacokinetics of O(6)-benzylguanine in pediatric patients with central nervous system tumors: a pediatric oncology group study. Clin Cancer Res. 2004 Aug 01; 10(15):5072-5.Clin Cancer Res2004-08-01T00:00:002004Pharmacokinetics of O(6)-benzylguanine in pediatric patients with central nervous system tumors: a pediatric oncology group study.18398615Menon-Andersen D, Mondick JT, Jayaraman B, Thompson PA, Blaney SM, Bernstein M, Bond M, Champagne M, Fossler MJ, Barrett JSCancer chemotherapy and pharmacologyPopulation pharmacokinetics of imatinib mesylate and its metabolite in children and young adults. Cancer Chemother Pharmacol. 2009 Jan; 63(2):229-38.Cancer Chemother Pharmacol2008-04-09T00:00:002008Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.18417739Haas-Kogan DA, Banerjee A, Kocak M, Prados MD, Geyer JR, Fouladi M, McKnight T, Poussaint TY, Broniscer A, Blaney SM, Boyett JM, Kun LENeuro-oncologyPhase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Neuro Oncol. 2008 Jun; 10(3):341-7.Neuro Oncol2008-04-16T00:00:002008Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.18497327Jakacki RI, Yates A, Blaney SM, Zhou T, Timmerman R, Ingle AM, Flom L, Prados MD, Adamson PC, Pollack IFNeuro-oncologyA phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood. Neuro Oncol. 2008 Aug; 10(4):569-76.Neuro Oncol2008-05-22T00:00:002008A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood.18669463Raetz EA, Cairo MS, Borowitz MJ, Blaney SM, Krailo MD, Leil TA, Reid JM, Goldenberg DM, Wegener WA, Carroll WL, Adamson PC, Children's Oncology Group Pilot StudyJournal of clinical oncology : official journal of the American Society of Clinical OncologyChemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study. J Clin Oncol. 2008 Aug 01; 26(22):3756-62.J Clin Oncol2008-08-01T00:00:002008Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study.18794549Jakacki RI, Hamilton M, Gilbertson RJ, Blaney SM, Tersak J, Krailo MD, Ingle AM, Voss SD, Dancey JE, Adamson PCJournal of clinical oncology : official journal of the American Society of Clinical OncologyPediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study. J Clin Oncol. 2008 Oct 20; 26(30):4921-7.J Clin Oncol2008-09-15T00:00:002008Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study.15659498Blaney SM, Boyett J, Friedman H, Gajjar A, Geyer R, Horowtiz M, Hunt D, Kieran M, Kun L, Packer R, Phillips P, Pollack IF, Prados M, Heideman RJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001). J Clin Oncol. 2005 Jan 20; 23(3):525-31.J Clin Oncol2005-01-20T00:00:002005Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).15735125Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, Krasin M, Dalton J, Hale G, Kun LE, Wallace D, Gilbertson RJ, Gajjar AJournal of clinical oncology : official journal of the American Society of Clinical OncologyAtypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol. 2005 Mar 01; 23(7):1491-9.J Clin Oncol2005-03-01T00:00:002005Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.15735131Blaney SM, Balis FM, Berg S, Arndt CA, Heideman R, Geyer JR, Packer R, Adamson PC, Jaeckle K, Klenke R, Aikin A, Murphy R, McCully C, Poplack DGJournal of clinical oncology : official journal of the American Society of Clinical OncologyIntrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol. 2005 Mar 01; 23(7):1555-63.J Clin Oncol2005-03-01T00:00:002005Intrathecal mafosfamide: a preclinical pharmacology and phase I trial.1712705Blaney SM, Balis FM, Poplack DGDrugsCurrent pharmacological treatment approaches to central nervous system leukaemia. Drugs. 1991 May; 41(5):702-16.Drugs1991-05-01T00:00:001991Current pharmacological treatment approaches to central nervous system leukaemia.1831994Blaney SM, Balis FM, Poplack DGOncology (Williston Park, N.Y.)Pharmacologic approaches to the treatment of meningeal malignancy. Oncology (Williston Park). 1991 May; 5(5):107-16; discussion 123, 127.Oncology (Williston Park)1991-05-01T00:00:001991Pharmacologic approaches to the treatment of meningeal malignancy.15073132Neville K, Parise RA, Thompson P, Aleksic A, Egorin MJ, Balis FM, McGuffey L, McCully C, Berg SL, Blaney SMClinical cancer research : an official journal of the American Association for Cancer ResearchPlasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates. Clin Cancer Res. 2004 Apr 01; 10(7):2525-9.Clin Cancer Res2004-04-01T00:00:002004Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates.15908649Berg SL, Blaney SM, Devidas M, Lampkin TA, Murgo A, Bernstein M, Billett A, Kurtzberg J, Reaman G, Gaynon P, Whitlock J, Krailo M, Harris MB, Children's Oncology GroupJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group. J Clin Oncol. 2005 May 20; 23(15):3376-82.J Clin Oncol2005-05-20T00:00:002005Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group.20563581Baxter PA, Thompson PA, McGuffey LM, Gibson BW, Dauser RC, Nuchtern JG, Shi C, Inloes R, Choy G, Redkar S, Blaney SMCancer chemotherapy and pharmacologyPlasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates. Cancer Chemother Pharmacol. 2011 Apr; 67(4):809-12.Cancer Chemother Pharmacol2010-06-19T00:00:002010Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates.16197722Adamson PC, Blaney SMCancer journal (Sudbury, Mass.)New approaches to drug development in pediatric oncology. Cancer J. 2005 Jul-Aug; 11(4):324-30.Cancer J2005-07-01T00:00:002005New approaches to drug development in pediatric oncology.20713864Fouladi M, Stewart CF, Blaney SM, Onar-Thomas A, Schaiquevich P, Packer RJ, Gajjar A, Kun LE, Boyett JM, Gilbertson RJJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study. J Clin Oncol. 2010 Sep 20; 28(27):4221-7.J Clin Oncol2010-08-16T00:00:002010Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study.16211885Neville KA, Blaney SMCancer treatment and researchLeptomeningeal cancer in the pediatric patient. Cancer Treat Res. 2005; 125:87-106.Cancer Treat Res2005-01-01T00:00:002005Leptomeningeal cancer in the pediatric patient.20860038Widemann BC, Arceci RJ, Jayaprakash N, Fox E, Zannikos P, Goodspeed W, Goodwin A, Wright JJ, Blaney SM, Adamson PC, Balis FMPediatric blood & cancerPhase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2011 Feb; 56(2):226-33.Pediatr Blood Cancer2010-09-21T00:00:002010Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology Group.21075780Yu L, Baxter PA, Zhao X, Liu Z, Wadhwa L, Zhang Y, Su JM, Tan X, Yang J, Adesina A, Perlaky L, Hurwitz M, Idamakanti N, Police SR, Hallenbeck PL, Blaney SM, Chintagumpala M, Hurwitz RL, Li XNNeuro-oncologyA single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models. Neuro Oncol. 2011 Jan; 13(1):14-27.Neuro Oncol2010-11-12T00:00:002010A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models.21149673Berg SL, Cairo MS, Russell H, Ayello J, Ingle AM, Lau H, Chen N, Adamson PC, Blaney SMJournal of clinical oncology : official journal of the American Society of Clinical OncologySafety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report. J Clin Oncol. 2011 Jan 20; 29(3):316-23.J Clin Oncol2010-12-13T00:00:002010Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report.15510203Jeha S, Kantarjian H, Irwin D, Shen V, Shenoy S, Blaney S, Camitta B, Pui CHLeukemiaEfficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial. Leukemia. 2005 Jan; 19(1):34-8.Leukemia2005-01-01T00:00:002005Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial.16317728Bomgaars LR, Megason GC, Pullen J, Langevin AM, Dale Weitman S, Hershon L, Kuhn JG, Bernstein M, Blaney SMPediatric blood & cancerPhase I trial of irofulven (MGI 114) in pediatric patients with solid tumors. Pediatr Blood Cancer. 2006 Aug; 47(2):163-8.Pediatr Blood Cancer2006-08-01T00:00:002006Phase I trial of irofulven (MGI 114) in pediatric patients with solid tumors.15701855Lau L, Supko JG, Blaney S, Hershon L, Seibel N, Krailo M, Qu W, Malkin D, Jimeno J, Bernstein M, Baruchel SClinical cancer research : an official journal of the American Association for Cancer ResearchA phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):672-7.Clin Cancer Res2005-01-15T00:00:002005A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study.16855840Stapleton SL, Reid JM, Thompson PA, Ames MM, McGovern RM, McGuffey L, Nuchtern J, Dauser R, Blaney SMCancer chemotherapy and pharmacologyPlasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates. Cancer Chemother Pharmacol. 2007 Mar; 59(4):461-6.Cancer Chemother Pharmacol2006-07-20T00:00:002006Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates.22184397Malempati S, Weigel B, Ingle AM, Ahern CH, Carroll JM, Roberts CT, Reid JM, Schmechel S, Voss SD, Cho SY, Chen HX, Krailo MD, Adamson PC, Blaney SMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2012 Jan 20; 30(3):256-62.J Clin Oncol2011-12-19T00:00:002011Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.16939963Stapleton S, Blaney SCancer investigationNew agents for intrathecal administration. Cancer Invest. 2006 Aug-Sep; 24(5):528-34.Cancer Invest2006-08-01T00:00:002006New agents for intrathecal administration.16953392Berg SL, Brueckner C, Nuchtern JG, Dauser R, McGuffey L, Blaney SMCancer chemotherapy and pharmacologyPlasma and cerebrospinal fluid pharmacokinetics of nelarabine in nonhuman primates. Cancer Chemother Pharmacol. 2007 May; 59(6):743-7.Cancer Chemother Pharmacol2006-09-05T00:00:002006Plasma and cerebrospinal fluid pharmacokinetics of nelarabine in nonhuman primates.16115942Berg SL, Bonate PL, Nuchtern JG, Dauser R, McGuffey L, Bernacky B, Blaney SMClinical cancer research : an official journal of the American Association for Cancer ResearchPlasma and cerebrospinal fluid pharmacokinetics of clofarabine in nonhuman primates. Clin Cancer Res. 2005 Aug 15; 11(16):5981-3.Clin Cancer Res2005-08-15T00:00:002005Plasma and cerebrospinal fluid pharmacokinetics of clofarabine in nonhuman primates.16135484Daw NC, Furman WL, Stewart CF, Iacono LC, Krailo M, Bernstein ML, Dancey JE, Speights RA, Blaney SM, Croop JM, Reaman GH, Adamson PC, Children's Oncology GroupJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2005 Sep 01; 23(25):6172-80.J Clin Oncol2005-09-01T00:00:002005Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study.22887890Muscal JA, Thompson PA, Horton TM, Ingle AM, Ahern CH, McGovern RM, Reid JM, Ames MM, Espinoza-Delgado I, Weigel BJ, Blaney SMPediatric blood & cancerA phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916). Pediatr Blood Cancer. 2013 Mar; 60(3):390-5.Pediatr Blood Cancer2012-08-09T00:00:002012A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916).16314955Chintagumpala MM, Friedman HS, Stewart CF, Kepner J, McLendon RE, Modrich PL, McCluggage C, Burger P, Holmes E, Thompson S, Rutka J, Michalski J, Woo S, Blaney SM, Kun LE, Horowitz ME, Pediatric Oncology Group StudyJournal of neuro-oncologyA phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group. J Neurooncol. 2006 Apr; 77(2):193-8.J Neurooncol2006-04-01T00:00:002006A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group.16373706Li XN, Shu Q, Su JM, Perlaky L, Blaney SM, Lau CCMolecular cancer therapeuticsValproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC. Mol Cancer Ther. 2005 Dec; 4(12):1912-22.Mol Cancer Ther2005-12-01T00:00:002005Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC.16877737Children's Oncology Group, Fouladi M, Furman WL, Chin T, Freeman BB, Dudkin L, Stewart CF, Krailo MD, Speights R, Ingle AM, Houghton PJ, Wright J, Adamson PC, Blaney SMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report. J Clin Oncol. 2006 Aug 01; 24(22):3678-85.J Clin Oncol2006-08-01T00:00:002006Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report.17634493Kieran MW, Packer RJ, Onar A, Blaney SM, Phillips P, Pollack IF, Geyer JR, Gururangan S, Banerjee A, Goldman S, Turner CD, Belasco JB, Broniscer A, Zhu Y, Frank E, Kirschmeier P, Statkevich P, Yver A, Boyett JM, Kun LEJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study. J Clin Oncol. 2007 Jul 20; 25(21):3137-43.J Clin Oncol2007-07-20T00:00:002007Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study.17239009Li XN, Shu Q, Su JM, Adesina AM, Wong KK, Perlaky L, Antalffy BA, Blaney SM, Lau CCNeuropathology and applied neurobiologyDifferential expression of survivin splice isoforms in medulloblastomas. Neuropathol Appl Neurobiol. 2007 Feb; 33(1):67-76.Neuropathol Appl Neurobiol2007-02-01T00:00:002007Differential expression of survivin splice isoforms in medulloblastomas.18202416Glade Bender JL, Adamson PC, Reid JM, Xu L, Baruchel S, Shaked Y, Kerbel RS, Cooney-Qualter EM, Stempak D, Chen HX, Nelson MD, Krailo MD, Ingle AM, Blaney SM, Kandel JJ, Yamashiro DJ, Children's Oncology Group StudyJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2008 Jan 20; 26(3):399-405.J Clin Oncol2008-01-20T00:00:002008Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study.17442992Malempati S, Nicholson HS, Reid JM, Blaney SM, Ingle AM, Krailo M, Stork LC, Melemed AS, McGovern R, Safgren S, Ames MM, Adamson PC, Children's Oncology GroupJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group. J Clin Oncol. 2007 Apr 20; 25(12):1505-11.J Clin Oncol2007-04-20T00:00:002007Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group.18278496Thompson PA, Gupta M, Rosner GL, Yu A, Barrett J, Bomgaars L, Bernstein ML, Blaney SM, Mondick JCancer chemotherapy and pharmacologyPharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group. Cancer Chemother Pharmacol. 2008 Nov; 62(6):1027-37.Cancer Chemother Pharmacol2008-02-16T00:00:002008Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group.17849472Jacob E, Scorsone K, Blaney SM, D'Argenio DZ, Berg SLPediatric blood & cancerSynergy of karenitecin and mafosfamide in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines. Pediatr Blood Cancer. 2008 Apr; 50(4):757-60.Pediatr Blood Cancer2008-04-01T00:00:002008Synergy of karenitecin and mafosfamide in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines.Authorship 1001085Authorship 100257918715950Bradley KA, Pollack IF, Reid JM, Adamson PC, Ames MM, Vezina G, Blaney S, Ivy P, Zhou T, Krailo M, Reaman G, Mehta MP, Children's Oncology GroupNeuro-oncologyMotexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study. Neuro Oncol. 2008 Oct; 10(5):752-8.Neuro Oncol2008-08-20T00:00:002008Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study.18586923Kim A, Fox E, Warren K, Blaney SM, Berg SL, Adamson PC, Libucha M, Byrley E, Balis FM, Widemann BCThe oncologistCharacteristics and outcome of pediatric patients enrolled in phase I oncology trials. Oncologist. 2008 Jun; 13(6):679-89.Oncologist2008-06-01T00:00:002008Characteristics and outcome of pediatric patients enrolled in phase I oncology trials.19065567Kieran MW, Supko JG, Wallace D, Fruscio R, Poussaint TY, Phillips P, Pollack I, Packer R, Boyett JM, Blaney S, Banerjee A, Geyer R, Friedman H, Goldman S, Kun LE, Macdonald T, Pediatric Brain Tumor ConsortiumPediatric blood & cancerPhase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors. Pediatr Blood Cancer. 2009 Feb; 52(2):169-76.Pediatr Blood Cancer2009-02-01T00:00:002009Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.19526240Muscal JA, Thompson PA, Giranda VL, Dayton BD, Bauch J, Horton T, McGuffey L, Nuchtern JG, Dauser RC, Gibson BW, Blaney SM, Su JMCancer chemotherapy and pharmacologyPlasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates. Cancer Chemother Pharmacol. 2010 Feb; 65(3):419-25.Cancer Chemother Pharmacol2009-06-13T00:00:002009Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates.Authorship 654409428032129Balis FM, Thompson PA, Mosse YP, Blaney SM, Minard CG, Weigel BJ, Fox ECancer chemotherapy and pharmacologyFirst-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children's Oncology Group Phase 1/Pilot Consortium. Cancer Chemother Pharmacol. 2017 Jan; 79(1):181-187.Cancer Chemother Pharmacol2016-12-28T00:00:002016First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children's Oncology Group Phase 1/Pilot Consortium.19671751Horton TM, Jenkins G, Pati D, Zhang L, Dolan ME, Ribes-Zamora A, Bertuch AA, Blaney SM, Delaney SL, Hegde M, Berg SLMolecular cancer therapeuticsPoly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity. Mol Cancer Ther. 2009 Aug; 8(8):2232-42.Mol Cancer Ther2009-08-11T00:00:002009Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity.2253232Blaney SM, Balis FM, Hegedus L, Heideman RL, McCully C, Murphy RF, Kelley JA, Poplack DGCancer researchPharmacokinetics and metabolism of cyclopentenyl cytosine in nonhuman primates. Cancer Res. 1990 Dec 15; 50(24):7915-9.Cancer Res1990-12-15T00:00:001990Pharmacokinetics and metabolism of cyclopentenyl cytosine in nonhuman primates.20049936Wagner LM, Perentesis JP, Reid JM, Ames MM, Safgren SL, Nelson MD, Ingle AM, Blaney SM, Adamson PCPediatric blood & cancerPhase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study. Pediatr Blood Cancer. 2010 Apr; 54(4):538-45.Pediatr Blood Cancer2010-04-01T00:00:002010Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study.20589651George RE, Lahti JM, Adamson PC, Zhu K, Finkelstein D, Ingle AM, Reid JM, Krailo M, Neuberg D, Blaney SM, Diller LPediatric blood & cancerPhase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Oct; 55(4):629-38.Pediatr Blood Cancer2010-10-01T00:00:002010Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study.20606092Fouladi M, Park JR, Stewart CF, Gilbertson RJ, Schaiquevich P, Sun J, Reid JM, Ames MM, Speights R, Ingle AM, Zwiebel J, Blaney SM, Adamson PCJournal of clinical oncology : official journal of the American Society of Clinical OncologyPediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report. J Clin Oncol. 2010 Aug 01; 28(22):3623-9.J Clin Oncol2010-07-06T00:00:002010Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report.20712019Souid AK, Dubowy RL, Ingle AM, Conlan MG, Sun J, Blaney SM, Adamson PCPediatric blood & cancerA pediatric phase I trial and pharmacokinetic study of ispinesib: a Children's Oncology Group phase I consortium study. Pediatr Blood Cancer. 2010 Dec 15; 55(7):1323-8.Pediatr Blood Cancer2010-08-13T00:00:002010A pediatric phase I trial and pharmacokinetic study of ispinesib: a Children's Oncology Group phase I consortium study.21263099Aplenc R, Blaney SM, Strauss LC, Balis FM, Shusterman S, Ingle AM, Agrawal S, Sun J, Wright JJ, Adamson PCJournal of clinical oncology : official journal of the American Society of Clinical OncologyPediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium. J Clin Oncol. 2011 Mar 01; 29(7):839-44.J Clin Oncol2011-01-24T00:00:002011Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium.21271676Rajagopal MU, Hathout Y, MacDonald TJ, Kieran MW, Gururangan S, Blaney SM, Phillips P, Packer R, Gordish-Dressman H, Rood BRProteomicsProteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study. Proteomics. 2011 Mar; 11(5):935-43.Proteomics2011-01-27T00:00:002011Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study.20658614Beaty O, Berg S, Blaney S, Malogolowkin M, Krailo M, Knight R, Schaiquevich P, Stewart C, Chen Z, Nelson M, Voss S, Ivy SP, Adamson PCPediatric blood & cancerA phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Sep; 55(3):440-5.Pediatr Blood Cancer2010-09-01T00:00:002010A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study.20708924Geyer JR, Stewart CF, Kocak M, Broniscer A, Phillips P, Douglas JG, Blaney SM, Packer RJ, Gururangan S, Banerjee A, Kieran MW, Kun LE, Gilbertson RJ, Boyett JMEuropean journal of cancer (Oxford, England : 1990)A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas. Eur J Cancer. 2010 Dec; 46(18):3287-93.Eur J Cancer2010-08-12T00:00:002010A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas.21764821Jakacki RI, Bouffet E, Adamson PC, Pollack IF, Ingle AM, Voss SD, Blaney SMNeuro-oncologyA phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study. Neuro Oncol. 2011 Aug; 13(8):910-5.Neuro Oncol2011-07-15T00:00:002011A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study.21910214Potter SL, Berg S, Ingle AM, Krailo M, Adamson PC, Blaney SMPediatric blood & cancerPhase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962). Pediatr Blood Cancer. 2012 Mar; 58(3):362-5.Pediatr Blood Cancer2011-09-09T00:00:002011Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962).22179104DuBois SG, Shusterman S, Reid JM, Ingle AM, Ahern CH, Baruchel S, Glade-Bender J, Ivy P, Adamson PC, Blaney SMCancer chemotherapy and pharmacologyTolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group study. Cancer Chemother Pharmacol. 2012 Apr; 69(4):1021-7.Cancer Chemother Pharmacol2011-12-18T00:00:002011Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group study.22988055Moss? YP, Lipsitz E, Fox E, Teachey DT, Maris JM, Weigel B, Adamson PC, Ingle MA, Ahern CH, Blaney SMClinical cancer research : an official journal of the American Association for Cancer ResearchPediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study. Clin Cancer Res. 2012 Nov 01; 18(21):6058-64.Clin Cancer Res2012-09-17T00:00:002012Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study.21671363Russell HV, Groshen SG, Ara T, DeClerck YA, Hawkins R, Jackson HA, Daldrup-Link HE, Marachelian A, Skerjanec A, Park JR, Katzenstein H, Matthay KK, Blaney SM, Villablanca JGPediatric blood & cancerA phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study. Pediatr Blood Cancer. 2011 Aug; 57(2):275-82.Pediatr Blood Cancer2010-11-12T00:00:002010A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.21690570Dubois SG, Shusterman S, Ingle AM, Ahern CH, Reid JM, Wu B, Baruchel S, Glade-Bender J, Ivy P, Grier HE, Adamson PC, Blaney SMClinical cancer research : an official journal of the American Association for Cancer ResearchPhase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study. Clin Cancer Res. 2011 Aug 01; 17(15):5113-22.Clin Cancer Res2011-06-20T00:00:002011Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study.22088484Baruchel S, Pappo A, Krailo M, Baker KS, Wu B, Villaluna D, Lee-Scott M, Adamson PC, Blaney SMEuropean journal of cancer (Oxford, England : 1990)A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group. Eur J Cancer. 2012 Mar; 48(4):579-85.Eur J Cancer2011-11-14T00:00:002011A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group.23592571Kilburn LB, Kocak M, Schaedeli Stark F, Meneses-Lorente G, Brownstein C, Hussain S, Chintagumpala M, Thompson PA, Gururangan S, Banerjee A, Paulino AC, Kun L, Boyett JM, Blaney SMNeuro-oncologyPhase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas. Neuro Oncol. 2013 Jun; 15(6):759-66.Neuro Oncol2013-04-16T00:00:002013Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas.Authorship 8407731028295182Rheingold SR, Tasian SK, Whitlock JA, Teachey DT, Borowitz MJ, Liu X, Minard CG, Fox E, Weigel BJ, Blaney SMBritish journal of haematologyA phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114). Br J Haematol. 2017 05; 177(3):467-474.Br J Haematol2017-03-14T00:00:002017A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114).22583571Day ES, Zhang L, Thompson PA, Zawaski JA, Kaffes CC, Gaber MW, Blaney SM, West JLNanomedicine (London, England)Vascular-targeted photothermal therapy of an orthotopic murine glioma model. Nanomedicine (Lond). 2012 Aug; 7(8):1133-48.Nanomedicine (Lond)2012-05-14T00:00:002012Vascular-targeted photothermal therapy of an orthotopic murine glioma model.22745043Warwick AB, Malempati S, Krailo M, Melemed A, Gorlick R, Ames MM, Safgren SL, Adamson PC, Blaney SMPediatric blood & cancerPhase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2013 Feb; 60(2):237-41.Pediatr Blood Cancer2012-06-28T00:00:002012Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group study.22790443Blaney SM, Kocak M, Gajjar A, Chintagumpala M, Merchant T, Kieran M, Pollack IF, Gururangan S, Geyer R, Phillips P, McLendon RE, Packer R, Goldman S, Banerjee A, Heideman R, Boyett JM, Kun LJournal of neuro-oncologyPilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001). J Neurooncol. 2012 Sep; 109(3):565-71.J Neurooncol2012-07-13T00:00:002012Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001).22962440Widemann BC, Kim A, Fox E, Baruchel S, Adamson PC, Ingle AM, Glade Bender J, Burke M, Weigel B, Stempak D, Balis FM, Blaney SMClinical cancer research : an official journal of the American Association for Cancer ResearchA phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report. Clin Cancer Res. 2012 Nov 01; 18(21):6011-22.Clin Cancer Res2012-09-07T00:00:002012A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report.8625085Ho PT, Zimmerman K, Wexler LH, Blaney S, Jarosinski P, Weaver-McClure L, Izraeli S, Balis FMCancerA prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults. Cancer. 1995 Dec 15; 76(12):2557-64.Cancer1995-12-15T00:00:001995A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults.8868094Blaney SM, Poplack DGCurrent opinion in oncologyCentral nervous system leukemia. Curr Opin Oncol. 1996 Jan; 8(1):13-9.Curr Opin Oncol1996-01-01T00:00:001996Central nervous system leukemia.8880395Blaney SM, Poplack DGInvestigational new drugsPharmacologic strategies for the treatment of meningeal malignancy. Invest New Drugs. 1996; 14(1):69-85.Invest New Drugs1996-01-01T00:00:001996Pharmacologic strategies for the treatment of meningeal malignancy.9440741Berg SL, Blaney SM, Adamson PC, O'Brien M, Poplack DG, Arndt C, Blatt J, Balis FMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers. J Clin Oncol. 1998 Jan; 16(1):181-6.J Clin Oncol1998-01-01T00:00:001998Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers.9554590Blaney SM, Takimoto C, Murry DJ, Kuttesch N, McCully C, Cole DE, Godwin K, Balis FMCancer chemotherapy and pharmacologyPlasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primates. Cancer Chemother Pharmacol. 1998; 41(6):464-8.Cancer Chemother Pharmacol1998-01-01T00:00:001998Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primates.9667269Langevin AM, Casto DT, Thomas PJ, Weitman SD, Kretschmar C, Grier H, Pratt C, Dubowy R, Bernstein M, Blaney S, Vietti TJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial of 9-aminocamptothecin in children with refractory solid tumors: a Pediatric Oncology Group study. J Clin Oncol. 1998 Jul; 16(7):2494-9.J Clin Oncol1998-07-01T00:00:001998Phase I trial of 9-aminocamptothecin in children with refractory solid tumors: a Pediatric Oncology Group study.Authorship 872397228237444Heikamp EB, Blaney SMThe Journal of pediatrics50 Years Ago in The Journal of Pediatrics: Diencephalic Syndromes of Infancy: Report of 3 Children with Emaciation Syndrome and Disproportionately Large Hands and Feet. J Pediatr. 2017 03; 182:113.J Pediatr2017-03-01T00:00:00201750 Years Ago in The Journal of Pediatrics: Diencephalic Syndromes of Infancy: Report of 3 Children with Emaciation Syndrome and Disproportionately Large Hands and Feet.10100598Serabe BM, Murry DJ, Dauser R, Nuchtern J, Durfee J, McGuffey L, Berg S, Blaney SMCancer chemotherapy and pharmacologyPlasma and CSF pharmacokinetics of ganciclovir in nonhuman primates. Cancer Chemother Pharmacol. 1999; 43(5):415-8.Cancer Chemother Pharmacol1999-01-01T00:00:001999Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates.10663645Balis FM, Blaney SM, McCully CL, Bacher JD, Murphy RF, Poplack DGCancer chemotherapy and pharmacologyMethotrexate distribution within the subarachnoid space after intraventricular and intravenous administration. Cancer Chemother Pharmacol. 2000; 45(3):259-64.Cancer Chemother Pharmacol2000-01-01T00:00:002000Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration.10741726Riva L, Blaney SM, Dauser R, Nuchtern JG, Durfee J, McGuffey L, Berg SLClinical cancer research : an official journal of the American Association for Cancer ResearchPharmacokinetics and cerebrospinal fluid penetration of CI-994 (N-acetyldinaline) in the nonhuman primate. Clin Cancer Res. 2000 Mar; 6(3):994-7.Clin Cancer Res2000-03-01T00:00:002000Pharmacokinetics and cerebrospinal fluid penetration of CI-994 (N-acetyldinaline) in the nonhuman primate.10962524Blaney SM, Poplack DGMedical oncology (Northwood, London, England)Neoplastic meningitis: diagnosis and treatment considerations. Med Oncol. 2000 Aug; 17(3):151-62.Med Oncol2000-08-01T00:00:002000Neoplastic meningitis: diagnosis and treatment considerations.11099129Nuchtern J, McGuffey L, Durfee J, Dauser R, Blaney SMComparative medicineModified procedure for implantation of subcutaneous central venous access devices in macaques (Macaca mulatta). Comp Med. 2000 Oct; 50(5):486-9.Comp Med2000-10-01T00:00:002000Modified procedure for implantation of subcutaneous central venous access devices in macaques (Macaca mulatta).11157020Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B, Hastings C, Blaney SM, Relling MV, Reaman GHJournal of clinical oncology : official journal of the American Society of Clinical OncologyRecombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma. J Clin Oncol. 2001 Feb 01; 19(3):697-704.J Clin Oncol2001-02-01T00:00:002001Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma.11990699Murry DJ, Cherrick I, Salama V, Berg S, Bernstein M, Kuttesch N, Blaney SMJournal of pediatric hematology/oncologyInfluence of phenytoin on the disposition of irinotecan: a case report. J Pediatr Hematol Oncol. 2002 Feb; 24(2):130-3.J Pediatr Hematol Oncol2002-02-01T00:00:002002Influence of phenytoin on the disposition of irinotecan: a case report.12142780Packer RJ, Biegel JA, Blaney S, Finlay J, Geyer JR, Heideman R, Hilden J, Janss AJ, Kun L, Vezina G, Rorke LB, Smith MJournal of pediatric hematology/oncologyAtypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol. 2002 Jun-Jul; 24(5):337-42.J Pediatr Hematol Oncol2002-06-01T00:00:002002Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.Authorship 8762431228751444Leary SES, Park JR, Reid JM, Ralya AT, Baruchel S, Wu B, Roberts TPL, Liu X, Minard CG, Fox E, Weigel B, Blaney SClinical cancer research : an official journal of the American Association for Cancer ResearchPediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report. Clin Cancer Res. 2017 Oct 15; 23(20):6062-6069.Clin Cancer Res2017-07-27T00:00:002017Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report.Authorship 876360828449393Geller JI, Perentesis JP, Liu X, Minard CG, Kudgus RA, Reid JM, Fox E, Blaney SM, Weigel BJPediatric blood & cancerA phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111). Pediatr Blood Cancer. 2017 Nov; 64(11).Pediatr Blood Cancer2017-04-27T00:00:002017A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111).28787259Moss? YP, Voss SD, Lim MS, Rolland D, Minard CG, Fox E, Adamson P, Wilner K, Blaney SM, Weigel BJJournal of clinical oncology : official journal of the American Society of Clinical OncologyTargeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study. J Clin Oncol. 2017 Oct 01; 35(28):3215-3221.J Clin Oncol2017-08-08T00:00:002017Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.Authorship 877165914997342Thompson PA, Berg SL, Aleksic A, Kerr JZ, McGuffey L, Dauser R, Nuchtern JG, Hausheer F, Blaney SMCancer chemotherapy and pharmacologyPlasma and cerebrospinal fluid pharmacokinetic study of BNP1350 in nonhuman primates. Cancer Chemother Pharmacol. 2004 Jun; 53(6):527-32.Cancer Chemother Pharmacol2004-03-02T00:00:002004Plasma and cerebrospinal fluid pharmacokinetic study of BNP1350 in nonhuman primates.14999430Adamson PC, Blaney SM, Widemann BC, Kitchen B, Murphy RF, Hannah AL, Cropp GF, Patel M, Gillespie AF, Whitcomb PG, Balis FMCancer chemotherapy and pharmacologyPediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101. Cancer Chemother Pharmacol. 2004 Jun; 53(6):482-8.Cancer Chemother Pharmacol2004-03-04T00:00:002004Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101.15231574Champagne MA, Capdeville R, Krailo M, Qu W, Peng B, Rosamilia M, Therrien M, Zoellner U, Blaney SM, Bernstein M, Children's Oncology Group phase 1 studyBloodImatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study. Blood. 2004 Nov 01; 104(9):2655-60.Blood2004-07-01T00:00:002004Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study.15457129Zhang L, Plon SE, Nuchtern JG, Burlingame S, Blaney S, Rousseau R, Berg SAnti-cancer drugsCyclin D and cisplatin cytotoxicity in primary neuroblastoma cell lines. Anticancer Drugs. 2004 Oct; 15(9):883-8.Anticancer Drugs2004-10-01T00:00:002004Cyclin D and cisplatin cytotoxicity in primary neuroblastoma cell lines.15768380Bomgaars L, Kerr J, Berg S, Kuttesch J, Klenke R, Blaney SMPediatric blood & cancerA phase I study of irinotecan administered on a weekly schedule in pediatric patients. Pediatr Blood Cancer. 2006 Jan; 46(1):50-5.Pediatr Blood Cancer2006-01-01T00:00:002006A phase I study of irinotecan administered on a weekly schedule in pediatric patients.16110498Greenberg ML, Fisher PG, Freeman C, Korones DN, Bernstein M, Friedman H, Blaney S, Hershon L, Zhou T, Chen Z, Kretschmar CPediatric blood & cancerEtoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study. Pediatr Blood Cancer. 2005 Oct 15; 45(5):644-8.Pediatr Blood Cancer2005-10-15T00:00:002005Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study.16292537Horton TM, Gannavarapu A, Blaney SM, D'Argenio DZ, Plon SE, Berg SLCancer chemotherapy and pharmacologyBortezomib interactions with chemotherapy agents in acute leukemia in vitro. Cancer Chemother Pharmacol. 2006 Jul; 58(1):13-23.Cancer Chemother Pharmacol2005-11-15T00:00:002005Bortezomib interactions with chemotherapy agents in acute leukemia in vitro.Authorship 103714117136402Thompson PA, Murry DJ, Rosner GL, Lunagomez S, Blaney SM, Berg SL, Camitta BM, Dreyer ZE, Bomgaars LRCancer chemotherapy and pharmacologyMethotrexate pharmacokinetics in infants with acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2007 May; 59(6):847-53.Cancer Chemother Pharmacol2006-11-29T00:00:002006Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia.17293590Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang Y, Hayes M, Murgo A, Weiner S, Boyett JMNeuro-oncologyPhase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Neuro Oncol. 2007 Apr; 9(2):145-60.Neuro Oncol2007-02-09T00:00:002007Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.17332297Horton TM, Pati D, Plon SE, Thompson PA, Bomgaars LR, Adamson PC, Ingle AM, Wright J, Brockman AH, Paton M, Blaney SMClinical cancer research : an official journal of the American Association for Cancer ResearchA phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study. Clin Cancer Res. 2007 Mar 01; 13(5):1516-22.Clin Cancer Res2007-03-01T00:00:002007A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study.17363534Weigel BJ, Blaney SM, Reid JM, Safgren SL, Bagatell R, Kersey J, Neglia JP, Ivy SP, Ingle AM, Whitesell L, Gilbertson RJ, Krailo M, Ames M, Adamson PCClinical cancer research : an official journal of the American Association for Cancer ResearchA phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study. Clin Cancer Res. 2007 Mar 15; 13(6):1789-93.Clin Cancer Res2007-03-15T00:00:002007A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study.Authorship 1053121017442993Rheingold SR, Hogarty MD, Blaney SM, Zwiebel JA, Sauk-Schubert C, Chandula R, Krailo MD, Adamson PC, Children's Oncology Group StudyJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2007 Apr 20; 25(12):1512-8.J Clin Oncol2007-04-20T00:00:002007Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study.17805488Bernardi RJ, Lowery AR, Thompson PA, Blaney SM, West JLJournal of neuro-oncologyImmunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines. J Neurooncol. 2008 Jan; 86(2):165-72.J Neurooncol2007-09-06T00:00:002007Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines.17909804Bernardi RJ, Bomgaars L, Fox E, Balis FM, Egorin MJ, Lagattuta TF, Aikin A, Whitcomb P, Renbarger J, Lieberman FS, Berg SL, Blaney SMCancer chemotherapy and pharmacologyPhase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis. Cancer Chemother Pharmacol. 2008 Jul; 62(2):355-61.Cancer Chemother Pharmacol2007-10-02T00:00:002007Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis.17959855Fox E, Razzouk BI, Widemann BC, Xiao S, O'Brien M, Goodspeed W, Reaman GH, Blaney SM, Murgo AJ, Balis FM, Adamson PCBloodPhase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma. Blood. 2008 Jan 15; 111(2):566-73.Blood2007-10-24T00:00:002007Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma.17971589Horton TM, Thompson PA, Berg SL, Adamson PC, Ingle AM, Dolan ME, Delaney SM, Hedge M, Weiss HL, Wu MF, Blaney SM, Children's Oncology Group StudyJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study. J Clin Oncol. 2007 Nov 01; 25(31):4922-8.J Clin Oncol2007-11-01T00:00:002007Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.18403755Shu Q, Wong KK, Su JM, Adesina AM, Yu LT, Tsang YT, Antalffy BC, Baxter P, Perlaky L, Yang J, Dauser RC, Chintagumpala M, Blaney SM, Lau CC, Li XNStem cells (Dayton, Ohio)Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma. Stem Cells. 2008 Jun; 26(6):1414-24.Stem Cells2008-04-10T00:00:002008Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma.18561175Bomgaars L, Thompson P, Berg S, Serabe B, Aleksic A, Blaney SPediatric blood & cancerValacyclovir and acyclovir pharmacokinetics in immunocompromised children. Pediatr Blood Cancer. 2008 Oct; 51(4):504-8.Pediatr Blood Cancer2008-10-01T00:00:002008Valacyclovir and acyclovir pharmacokinetics in immunocompromised children.Authorship 105668818989889Geller JI, Wall D, Perentesis J, Blaney SM, Bernstein M, Pediatric Oncology Group study 9376Pediatric blood & cancerPhase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a Pediatric Oncology Group study (POG 9376). Pediatr Blood Cancer. 2009 Mar; 52(3):346-50.Pediatr Blood Cancer2009-03-01T00:00:002009Phase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a Pediatric Oncology Group study (POG 9376).19043710Kilburn LB, Bonate PL, Blaney SM, McGuffey L, Nuchtern JG, Dauser R, Thompson P, Gibson BW, Berg SLCancer chemotherapy and pharmacologyPlasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates. Cancer Chemother Pharmacol. 2009 Jul; 64(2):335-40.Cancer Chemother Pharmacol2008-11-29T00:00:002008Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates.19170226McGregor LM, Spunt SL, Furman WL, Stewart CF, Schaiquevich P, Krailo MD, Speights R, Ivy P, Adamson PC, Blaney SMCancerPhase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group study. Cancer. 2009 Apr 15; 115(8):1765-75.Cancer2009-04-15T00:00:002009Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group study.20068084Jacobs S, Fox E, Krailo M, Hartley G, Navid F, Wexler L, Blaney SM, Goodwin A, Goodspeed W, Balis FM, Adamson PC, Widemann BCClinical cancer research : an official journal of the American Association for Cancer ResearchPhase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group. Clin Cancer Res. 2010 Jan 15; 16(2):750-4.Clin Cancer Res2010-01-12T00:00:002010Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group.20486176Berg SL, Winick N, Ingle AM, Adamson PC, Blaney SMPediatric blood & cancerReasons for participation in optional pharmacokinetic studies in children with cancer: a Children's Oncology Group phase 1 consortium study. Pediatr Blood Cancer. 2010 Jul 15; 55(1):119-22.Pediatr Blood Cancer2010-07-15T00:00:002010Reasons for participation in optional pharmacokinetic studies in children with cancer: a Children's Oncology Group phase 1 consortium study.20511191Yu L, Baxter PA, Voicu H, Gurusiddappa S, Zhao Y, Adesina A, Man TK, Shu Q, Zhang YJ, Zhao XM, Su JM, Perlaky L, Dauser R, Chintagumpala M, Lau CC, Blaney SM, Rao PH, Leung HC, Li XNNeuro-oncologyA clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neuro Oncol. 2010 Jun; 12(6):580-94.Neuro Oncol2010-02-08T00:00:002010A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo.21110217Day ES, Thompson PA, Zhang L, Lewinski NA, Ahmed N, Drezek RA, Blaney SM, West JLJournal of neuro-oncologyNanoshell-mediated photothermal therapy improves survival in a murine glioma model. J Neurooncol. 2011 Aug; 104(1):55-63.J Neurooncol2010-11-26T00:00:002010Nanoshell-mediated photothermal therapy improves survival in a murine glioma model.21115653Su JM, Li XN, Thompson P, Ou CN, Ingle AM, Russell H, Lau CC, Adamson PC, Blaney SMClinical cancer research : an official journal of the American Association for Cancer ResearchPhase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group report. Clin Cancer Res. 2011 Feb 01; 17(3):589-97.Clin Cancer Res2010-11-29T00:00:002010Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group report.21149652Warren KE, Goldman S, Pollack IF, Fangusaro J, Schaiquevich P, Stewart CF, Wallace D, Blaney SM, Packer R, Macdonald T, Jakacki R, Boyett JM, Kun LEJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018. J Clin Oncol. 2011 Jan 20; 29(3):324-9.J Clin Oncol2010-12-13T00:00:002010Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018.21809989McLendon RE, Adekunle A, Rajaram V, Ko?ak M, Blaney SMArchives of pathology & laboratory medicineEmbryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study. Arch Pathol Lab Med. 2011 Aug; 135(8):984-93.Arch Pathol Lab Med2011-08-01T00:00:002011Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study.22791883Glade Bender J, Blaney SM, Borinstein S, Reid JM, Baruchel S, Ahern C, Ingle AM, Yamashiro DJ, Chen A, Weigel B, Adamson PC, Park JRClinical cancer research : an official journal of the American Association for Cancer ResearchA phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium report. Clin Cancer Res. 2012 Sep 15; 18(18):5081-9.Clin Cancer Res2012-07-12T00:00:002012A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium report.23002039Blaney SM, Tagen M, Onar-Thomas A, Berg SL, Gururangan S, Scorsone K, Su J, Goldman S, Kieran MW, Kun L, Boyett J, Stewart CPediatric blood & cancerA phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study. Pediatr Blood Cancer. 2013 Apr; 60(4):627-32.Pediatr Blood Cancer2012-09-21T00:00:002012A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.Authorship 101292129090524Rau RE, Dreyer Z, Choi MR, Liang W, Skowronski R, Allamneni KP, Devidas M, Raetz EA, Adamson PC, Blaney SM, Loh ML, Hunger SPPediatric blood & cancerOutcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2018 03; 65(3).Pediatr Blood Cancer2017-11-01T00:00:002017Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group.Authorship 88281614Authorship 8833781Authorship 88424110Authorship 8855571029176358Blaney SMCurrent opinion in pediatricsRecent advances in pediatric oncology. Curr Opin Pediatr. 2018 02; 30(1):1-2.Curr Opin Pediatr2018-02-01T00:00:002018Recent advances in pediatric oncology.29693796Chuk MK, Widemann BC, Minard CG, Liu X, Kim A, Bernhardt MB, Kudgus RA, Reid JM, Voss SD, Blaney S, Fox E, Weigel BJPediatric blood & cancerA phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group. Pediatr Blood Cancer. 2018 08; 65(8):e27077.Pediatr Blood Cancer2018-04-25T00:00:002018A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.29719113Schafer ES, Rau RE, Berg S, Liu X, Minard CG, D'Adamo D, Scott R, Reyderman L, Martinez G, Devarajan S, Reid JM, Fox E, Weigel BJ, Blaney SMPediatric blood & cancerA phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314). Pediatr Blood Cancer. 2018 08; 65(8):e27066.Pediatr Blood Cancer2018-05-02T00:00:002018A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314).23554030Hummel TR, Wagner L, Ahern C, Fouladi M, Reid JM, McGovern RM, Ames MM, Gilbertson RJ, Horton T, Ingle AM, Weigel B, Blaney SMPediatric blood & cancerA pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study. Pediatr Blood Cancer. 2013 Sep; 60(9):1452-7.Pediatr Blood Cancer2013-03-28T00:00:002013A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study.23598171Moss? YP, Lim MS, Voss SD, Wilner K, Ruffner K, Laliberte J, Rolland D, Balis FM, Maris JM, Weigel BJ, Ingle AM, Ahern C, Adamson PC, Blaney SMThe Lancet. OncologySafety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. Lancet Oncol. 2013 May; 14(6):472-80.Lancet Oncol2013-04-16T00:00:002013Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.Authorship 1016034true1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professor29090526Kilburn LB, Kocak M, Baxter P, Poussaint TY, Paulino AC, McIntyre C, Lemenuel-Diot A, Lopez-Diaz C, Kun L, Chintagumpala M, Su JM, Broniscer A, Baker JN, Hwang EI, Fouladi M, Boyett JM, Blaney SMPediatric blood & cancerA pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas. Pediatr Blood Cancer. 2018 Feb; 65(2).Pediatr Blood Cancer2017-11-01T00:00:002017A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.D020714Concepts & Ideas34912780.762926Maximum Tolerated DoseD000970Chemicals & Drugs1665142590.195977Antineoplastic AgentsAuthorship 12261911Authorship 12262010Authorship 1226211224097866Thompson PA, Drissi R, Muscal JA, Panditharatna E, Fouladi M, Ingle AM, Ahern CH, Reid JM, Lin T, Weigel BJ, Blaney SMClinical cancer research : an official journal of the American Association for Cancer ResearchA phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112). Clin Cancer Res. 2013 Dec 01; 19(23):6578-84.Clin Cancer Res2013-10-04T00:00:002013A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112).23956055Weigel B, Malempati S, Reid JM, Voss SD, Cho SY, Chen HX, Krailo M, Villaluna D, Adamson PC, Blaney SMPediatric blood & cancerPhase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2014 Mar; 61(3):452-6.Pediatr Blood Cancer2013-08-17T00:00:002013Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group.23857966Glade Bender JL, Lee A, Reid JM, Baruchel S, Roberts T, Voss SD, Wu B, Ahern CH, Ingle AM, Harris P, Weigel BJ, Blaney SMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report. J Clin Oncol. 2013 Aug 20; 31(24):3034-43.J Clin Oncol2013-07-15T00:00:002013Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report.AMYSANYAHUMBIAMY SANYAHUMBI0.000000000000000.000000000000005510SANYAHUMBI, AMYAssistant ProfessorD002675Living Beings2154162000.306461Child, PreschoolD009369Disorders2056151140.155158NeoplasmsAuthorship 91982917Authorship 9344349Authorship 935953130122620Cole PD, McCarten KM, Pei Q, Spira M, Metzger ML, Drachtman RA, Horton TM, Bush R, Blaney SM, Weigel BJ, Kelly KMThe Lancet. OncologyBrentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial. Lancet Oncol. 2018 09; 19(9):1229-1238.Lancet Oncol2018-08-16T00:00:002018Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial.30614919Blaney SMCurrent opinion in pediatricsEditorial: Recent advances in pediatric oncology. Curr Opin Pediatr. 2019 02; 31(1):1-2.Curr Opin Pediatr2019-02-01T00:00:002019Editorial: Recent advances in pediatric oncology.D020295Disorders431080.892262Brain Stem NeoplasmsDepartment of PediatricsPediatrics-Hem/Onc Clin ResearchPediatrics-CardiologyPediatrics-Hematology & OncologyPediatrics-OncologyBaylor College of MedicineSCOTTBASINGERSCOTT BASINGER0.000000000000000.0000000000000014BASINGER, SCOTTAssociate ProfessorLISABOMGAARSLISA BOMGAARS0.000000000000000.000000000000001961BOMGAARS, LISAProfessorSTACEYBERGSTACEY BERG0.000000000000000.000000000000003449BERG, STACEYProfessorDAVIDPOPLACKDAVID POPLACK0.000000000000000.000000000000003400POPLACK, DAVIDProfessor2.759150.00266474627research areas3.979470.010258945coauthor of348.39735.359960similar to11212selected publicationsJACKSUJACK SU0.000000000000000.000000000000003543SU, JACKAssociate ProfessorMALCOLMBRENNERMALCOLM BRENNER0.000000000000000.000000000000003564BRENNER, MALCOLMDistinguished Service ProfessorDANGOMBOSDAN GOMBOS0.000000000000000.000000000000003684GOMBOS, DANAssociate ProfessorAuthorship 9422171430777875Moss? YP, Fox E, Teachey DT, Reid JM, Safgren SL, Carol H, Lock RB, Houghton PJ, Smith MA, Hall D, Barkauskas DA, Krailo M, Voss SD, Berg SL, Blaney SM, Weigel BJClinical cancer research : an official journal of the American Association for Cancer ResearchA Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921). Clin Cancer Res. 2019 06 01; 25(11):3229-3238.Clin Cancer Res2019-02-18T00:00:002019A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921).ERICSCHAFERERIC SCHAFER29.70508570000000-95.401808700000004413SCHAFER, ERICAssociate ProfessorAuthorship 944021230544145Bertagnolli MM, Blaney SM, Blanke CD, Curran WJ, Dancey J, Mannel RS, O'Dwyer PJ, Schnall MD, Wolmark N, Coalition of Cancer Cooperative GroupsJournal of the National Cancer InstituteCurrent Activities of the Coalition of Cancer Cooperative Groups. J Natl Cancer Inst. 2019 01 01; 111(1):11-18.J Natl Cancer Inst2019-01-01T00:00:002019Current Activities of the Coalition of Cancer Cooperative Groups.Authorship 12840718Authorship 128870323658322Liu Z, Zhao X, Mao H, Baxter PA, Huang Y, Yu L, Wadhwa L, Su JM, Adesina A, Perlaky L, Hurwitz M, Idamakanti N, Police SR, Hallenbeck PL, Hurwitz RL, Lau CC, Chintagumpala M, Blaney SM, Li XNNeuro-oncologyIntravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma. Neuro Oncol. 2013 Sep; 15(9):1173-85.Neuro Oncol2013-05-07T00:00:002013Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma.23836190Fouladi M, Stewart CF, Blaney SM, Onar-Thomas A, Schaiquevich P, Packer RJ, Goldman S, Geyer JR, Gajjar A, Kun LE, Boyett JM, Gilbertson RJJournal of neuro-oncologyA molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study. J Neurooncol. 2013 Sep; 114(2):173-9.J Neurooncol2013-07-09T00:00:002013A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study.Authorship 1123951Authorship 1113338Authorship 11145210true1ProfessorProfessortrue1Distinguished Service ProfessorDistinguished Service Professortrue1Associate ProfessorAssociate ProfessorAuthorship 9610201431724813Schafer ES, Rau RE, Berg SL, Liu X, Minard CG, Bishop AJR, Romero JC, Hicks MJ, Nelson MD, Voss S, Reid JM, Fox E, Weigel BJ, Blaney SMPediatric blood & cancerPhase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411). Pediatr Blood Cancer. 2020 02; 67(2):e28073.Pediatr Blood Cancer2019-11-14T00:00:002019Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411).RAYNEROUCERAYNE ROUCE0.000000000000000.000000000000005730ROUCE, RAYNEAssociate ProfessorAuthorship 9805641632009149Baxter PA, Su JM, Onar-Thomas A, Billups CA, Li XN, Poussaint TY, Smith ER, Thompson P, Adesina A, Ansell P, Giranda V, Paulino A, Kilburn L, Quaddoumi I, Broniscer A, Blaney SM, Dunkel IJ, Fouladi MNeuro-oncologyA phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study. Neuro Oncol. 2020 06 09; 22(6):875-885.Neuro Oncol2020-06-09T00:00:002020A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study.true1Associate ProfessorAssociate ProfessorAuthorship 1151483true1ProfessorProfessorAuthorship 9873131132285998Su JM, Murray JC, McNall-Knapp RY, Bowers DC, Shah S, Adesina AM, Paulino AC, Jo E, Mo Q, Baxter PA, Blaney SMPediatric blood & cancerA phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma. Pediatr Blood Cancer. 2020 06; 67(6):e28283.Pediatr Blood Cancer2020-04-14T00:00:002020A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma.Authorship 1185834Authorship 10033901033095287Greengard E, Mosse YP, Liu X, Minard CG, Reid JM, Voss S, Wilner K, Fox E, Balis F, Blaney SM, Adamson PC, Weigel BJCancer chemotherapy and pharmacologySafety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212). Cancer Chemother Pharmacol. 2020 12; 86(6):829-840.Cancer Chemother Pharmacol2020-10-23T00:00:002020Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212).Authorship 1153078Authorship 10111211033568345Foster JH, Voss SD, Hall DC, Minard CG, Balis FM, Wilner K, Berg SL, Fox E, Adamson PC, Blaney SM, Weigel BJ, Moss? YPClinical cancer research : an official journal of the American Association for Cancer ResearchActivity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912). Clin Cancer Res. 2021 07 01; 27(13):3543-3548.Clin Cancer Res2021-02-10T00:00:002021Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912).Authorship 1202832Authorship 1141682Authorship 10141313033741710Arabzade A, Zhao Y, Varadharajan S, Chen HC, Jessa S, Rivas B, Stuckert AJ, Solis M, Kardian A, Tlais D, Golbourn BJ, Stanton AJ, Chan YS, Olson C, Karlin KL, Kong K, Kupp R, Hu B, Injac SG, Ngo M, Wang PR, De Le?n LA, Sahm F, Kawauchi D, Pfister SM, Lin CY, Hodges HC, Singh I, Westbrook TF, Chintagumpala MM, Blaney SM, Parsons DW, Pajtler KW, Agnihotri S, Gilbertson RJ, Yi J, Jabado N, Kleinman CL, Bertrand KC, Deneen B, Mack SCCancer discoveryZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma. Cancer Discov. 2021 09; 11(9):2200-2215.Cancer Discov2021-03-19T00:00:002021ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.Authorship 1019329834032552Kamdar KY, Kim TO, Doherty EE, Pfeiffer TM, Qasim SL, Suell MN, Yates AM, Blaney SMPediatric hematology and oncologyCOVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas. Pediatr Hematol Oncol. 2021 Nov; 38(8):695-706.Pediatr Hematol Oncol2021-05-25T00:00:002021COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas.Authorship 115932234347089Su JM, Kilburn LB, Mansur DB, Krailo M, Buxton A, Adekunle A, Gajjar A, Adamson PC, Weigel B, Fox E, Blaney SM, Fouladi MNeuro-oncologyPhase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report. Neuro Oncol. 2022 04 01; 24(4):655-664.Neuro Oncol2022-04-01T00:00:002022Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report.Authorship 102722111true1ProfessorProfessorAuthorship 1194023true1Associate ProfessorAssociate ProfessorAuthorship 160411Authorship 169912Authorship 170458Authorship 175486Authorship 177568true1Associate ProfessorAssociate ProfessorAuthorship 1222359Authorship 183897Authorship 19949Authorship 20679Authorship 144981Authorship 1845511Authorship 232456true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessorAuthorship 1869410Authorship 230628Authorship 196693Authorship 265603Authorship 288322Authorship 3142012Authorship 3279713Authorship 2674913Authorship 358272Authorship 360818Authorship 25353Authorship 27947Authorship 284647Authorship 402309Authorship 420301Authorship 298046Authorship 287061Authorship 432505Authorship 305657Authorship 3221714Authorship 342013Authorship 480893Authorship 14351111Authorship 143514Authorship 14353524753394Widemann BC, Babovic-Vuksanovic D, Dombi E, Wolters PL, Goldman S, Martin S, Goodwin A, Goodspeed W, Kieran MW, Cohen B, Blaney SM, King A, Solomon J, Patronas N, Balis FM, Fox E, Steinberg SM, Packer RJPediatric blood & cancerPhase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. Pediatr Blood Cancer. 2014 Sep; 61(9):1598-602.Pediatr Blood Cancer2014-04-22T00:00:002014Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.Fouladi M, Perentesis JP, Phillips CL, Leary S, Reid JM, McGovern RM, Ingle AM, Ahern CH, Ames MM, Houghton P, Doyle LA, Weigel B, Blaney SM.A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study.A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study. 2014; 61(7):1246-1251.2014-03-24T00:00:002014A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group studyBagatell R, Norris R, Ingle AM, Ahern C, Voss S, Fox E, Little AR, Weigel BJ, Adamson PC, Blaney S.Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group Study.Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group Study. 2014; 61(5):833-839.2014-01-01T00:00:002014Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group StudyAuthorship 377101Authorship 3713510Authorship 374775Authorship 390011Authorship 378172Authorship 556633Authorship 400291Authorship 579825Authorship 4516411Authorship 4725811Authorship 646559Authorship 479552Authorship 656438Authorship 6870514Authorship 491274Authorship 698961Authorship 514218Authorship 721983Authorship 5168316Authorship 5367612Authorship 531375Authorship 537462Authorship 756016Authorship 764293Authorship 7840310Authorship 785243Authorship 78896Authorship 556681Authorship 564711Authorship 562357Authorship 5714411Authorship 575104Authorship 572034Authorship 581079Authorship 588986Authorship 840477Authorship 605547Authorship 614402Authorship 621592Authorship 631567Authorship 897754Authorship 6537816Authorship 655244Authorship 658618Authorship 9215610Authorship 658482Authorship 1535239Authorship 67561425307519Burke MJ, Ahern C, Weigel BJ, Poirier JT, Rudin CM, Chen Y, Cripe TP, Bernhardt MB, Blaney SMPediatric blood & cancerPhase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group. Pediatr Blood Cancer. 2015 May; 62(5):743-50.Pediatr Blood Cancer2014-10-12T00:00:002014Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group.Authorship 677902Authorship 984003Authorship 7070214Authorship 717605Authorship 749402Authorship 778376Authorship 15595318Authorship 15610210